120 related articles for article (PubMed ID: 38087904)
21. Melting, glass transition, and apparent heat capacity of α-D-glucose by thermal analysis.
Magoń A; Pyda M
Carbohydr Res; 2011 Nov; 346(16):2558-66. PubMed ID: 22000766
[TBL] [Abstract][Full Text] [Related]
22. Crystallization of Amorphous Nimesulide: The Relationship between Crystal Growth Kinetics and Liquid Dynamics.
Shi Q; Wang Y; Kong J
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049679
[TBL] [Abstract][Full Text] [Related]
23. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
[TBL] [Abstract][Full Text] [Related]
24. Thermal characteristics of crystalline and amorphous 2'-fucosyllactose, a human milk oligosaccharide.
Ahn S; Chung D
Food Chem; 2023 Jun; 410():135438. PubMed ID: 36652796
[TBL] [Abstract][Full Text] [Related]
25. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.
Hancock BC; Shamblin SL; Zografi G
Pharm Res; 1995 Jun; 12(6):799-806. PubMed ID: 7667182
[TBL] [Abstract][Full Text] [Related]
26. Glass transition, crystallization kinetics, and inter-conformer relaxation dynamics of amorphous mitotane and related compounds.
Romanini M; Pérez Valmaseda A; Macovez R
Int J Pharm; 2022 Dec; 629():122390. PubMed ID: 36379398
[TBL] [Abstract][Full Text] [Related]
27. Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems.
Kilpeläinen T; Pajula K; Ervasti T; Uurasjärvi E; Koistinen A; Korhonen O
Eur J Pharm Biopharm; 2020 Oct; 155():49-54. PubMed ID: 32795500
[TBL] [Abstract][Full Text] [Related]
28. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
[TBL] [Abstract][Full Text] [Related]
29. Metastability and transformation of polymorphic crystals in biodegradable poly(butylene adipate).
Gan Z; Kuwabara K; Abe H; Iwata T; Doi Y
Biomacromolecules; 2004; 5(2):371-8. PubMed ID: 15002996
[TBL] [Abstract][Full Text] [Related]
30. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
[TBL] [Abstract][Full Text] [Related]
31. Influence of Nucleation on Relaxation, Molecular Cooperativity, and Physical Stability of Celecoxib Glass.
Han X; Dai K; Kawakami K
Mol Pharm; 2024 Apr; 21(4):1794-1803. PubMed ID: 38401048
[TBL] [Abstract][Full Text] [Related]
32. Mapping the solid-state properties of crystalline lysozyme during pharmaceutical unit-operations.
Mohammad MA; Grimsey IM; Forbes RT
J Pharm Biomed Anal; 2015 Oct; 114():176-83. PubMed ID: 26068908
[TBL] [Abstract][Full Text] [Related]
33. Influence of low-temperature nucleation on the crystallization process of poly(L-lactide).
Hernández Sánchez F; Molina Mateo J; Romero Colomer FJ; Salmerón Sánchez M; Gómez Ribelles JL; Mano JF
Biomacromolecules; 2005; 6(6):3283-90. PubMed ID: 16283757
[TBL] [Abstract][Full Text] [Related]
34. Amorphization of different furosemide polymorphic forms during ball milling: Tracking solid-to-solid phase transformations.
Wang M; Gong J; Rades T; Martins ICB
Int J Pharm; 2023 Dec; 648():123573. PubMed ID: 37931725
[TBL] [Abstract][Full Text] [Related]
35. Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol.
Schammé B; Couvrat N; Malpeli P; Delbreilh L; Dupray V; Dargent É; Coquerel G
Int J Pharm; 2015 Jul; 490(1-2):248-57. PubMed ID: 26003417
[TBL] [Abstract][Full Text] [Related]
36. Preparation and transformation of true nifedipine polymorphs: investigated with differential scanning calorimetry and X-Ray diffraction pattern fitting methods.
Grooff D; Liebenberg W; De Villiers MM
J Pharm Sci; 2011 May; 100(5):1944-57. PubMed ID: 21259235
[TBL] [Abstract][Full Text] [Related]
37. Anomalous nucleation of crystals within amorphous germanium nanowires during thermal annealing.
Camara O; Mir AH; Greaves G; Donnelly SE; Hinks JA
Nanotechnology; 2021 Apr; 32(28):. PubMed ID: 33254162
[TBL] [Abstract][Full Text] [Related]
38. Nucleation and crystallization kinetics of hydrated amorphous lactose above the glass transition temperature.
Schmitt EA; Law D; Zhang GG
J Pharm Sci; 1999 Mar; 88(3):291-6. PubMed ID: 10052985
[TBL] [Abstract][Full Text] [Related]
39. Thermal and structural behavior of milk fat. 3. Influence of cooling rate and droplet size on cream crystallization.
Lopez C; Bourgaux C; Lesieur P; Bernadou S; Keller G; Ollivon M
J Colloid Interface Sci; 2002 Oct; 254(1):64-78. PubMed ID: 12702426
[TBL] [Abstract][Full Text] [Related]
40. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
